期刊文献+

SIRT6延缓动脉粥样硬化病程进展的机制研究

Mechanism of SIRT6 Delaying the Progress of Atherosclerosis
下载PDF
导出
摘要 目的分析SIRT6延缓动脉粥样硬化病程进展的机制。方法本实验时间为2022年1-10月。动物实验:将10只SPF级野生型雄性C57BL小鼠作为对照组,随机选取10只雄性ApoE^(-/-)小鼠作为动脉粥样硬化组,剩余10只雄性ApoE^(-/-)小鼠作为动脉粥样硬化+SIRT6^(-/-)组。对照组小鼠采用普通饲料喂养16周。动脉粥样硬化组和动脉粥样硬化+SIRT6^(-/-)组小鼠采用高脂饲料喂养16周以构建动脉粥样硬化模型。此外,动脉粥样硬化+SIRT6^(-/-)组小鼠采用CreLoxP方法构建巨噬细胞特异性SIRT6缺陷模型。采用HE染色检测各组小鼠动脉粥样硬化斑块面积,Western blot法检测各组小鼠主动脉组织中SIRT6、IL-32、细胞间黏附分子1(ICAM-1)表达水平,免疫荧光染色检测各组小鼠主动脉组织中CD31表达情况。细胞实验:取对数生长期的巨噬细胞RAW 264.7,将其随机分为对照组(不进行干预)、动脉粥样硬化组〔采用50μg/ml的氧化型低密度脂蛋白(ox-LDL)干预24 h〕、动脉粥样硬化+Ad-SIRT6组(转染腺病毒Ad-SIRT6,24 h后用50μg/ml的ox-LDL干预24 h)、动脉粥样硬化+Ad-SIRT6+Ad-IL-32组(转染腺病毒Ad-SIRT6,24 h后转染腺病毒Ad-IL-32,24 h后用50μg/ml的ox-LDL干预24 h)。采用油红O染色检测各组巨噬细胞中脂质含量。结果HE染色结果显示,对照组小鼠动脉粥样硬化斑块面积为0;动脉粥样硬化组小鼠动脉粥样硬化斑块面积小于动脉粥样硬化+SIRT6^(-/-)组(P<0.05)。动脉粥样硬化组、动脉粥样硬化+SIRT6^(-/-)组小鼠主动脉组织中SIRT6表达水平低于对照组,IL-32、ICAM-1表达水平高于对照组(P<0.05);动脉粥样硬化+SIRT6^(-/-)组小鼠主动脉组织中SIRT6表达水平低于动脉粥样硬化组,IL-32、ICAM-1表达水平高于动脉粥样硬化组(P<0.05)。免疫荧光染色结果显示,对照组小鼠血管内膜表面光滑完整,无增厚现象;动脉粥样硬化组小鼠可见粥样硬化斑块形成,血管内膜表面欠光滑且不完整;相较于动脉粥样硬化组,动脉粥样硬化+SIRT6^(-/-)组小鼠血管内膜下可见明显的脂质沉积,血管内膜表面欠光滑且不完整。油红O染色结果显示,对照组巨噬细胞中并未发现脂质堆积,动脉粥样硬化组巨噬细胞中脂质含量较对照组明显增多,动脉粥样硬化+Ad-SIRT6组巨噬细胞中脂质含量较动脉粥样硬化组明显减少,动脉粥样硬化+AdSIRT6+Ad-IL-32组巨噬细胞中脂质含量较动脉粥样硬化+Ad-SIRT6组明显增多。结论SIRT6可通过下调IL-32的表达来抑制炎症反应,从而改善内皮细胞功能,减少巨噬细胞中脂质沉积,从而减少泡沫细胞的形成,进而抑制动脉粥样硬化斑块的形成,最终延缓动脉粥样硬化病情进展。 Objective To analyze the mechanism of SIRT6 delaying the progress of atherosclerosis.Methods The experiment was conducted from January to October 2022.Animal experiment:10 SPF wild-type male C57BL mice were selected as control group,10 male ApoE^(-/-)mice were randomly selected as atherosclerosis group,and the remaining 10 male ApoE^(-/-)mice were selected as atherosclerosis+SIRT6^(-/-)group.Mice in control group were fed with normal diet for 16 weeks.Mice in atherosclerosis group and atherosclerosis+SIRT6^(-/-)group were fed with high fat diet for 16 weeks to establish atherosclerosis model.In addition,the macrophage-specific SIRT6 deficiency model was established in atherosclerosis+SIRT6^(-/-)group mice by Cre-LoxP method.The atherosclerotic plaque area of mice in each group was detected by HE staining,the expression levels of SIRT6,IL-32 and intercellular cell adhesion molecule-1(ICAM-1)in the aorta tissue of mice in each group were detected by Western blot,and the expression of CD31 in the aorta tissue of mice in each group was detected by immunofluorescence staining.Cell experiment:macrophage RAW 264.7 of logarithmic growth stage was selected and randomly divided into control group(no intervention),atherosclerosis group[treated with 50μg/ml oxidized low-density lipoprotein(ox-LDL)for 24 h],atherosclerosis+Ad-SIRT6 group(transfected adenovirus Ad-SIRT6,after 24 h treated with 50μg/ml ox-LDL for 24 h)and atherosclerosis+Ad-SIRT6+Ad-IL-32 group(transfected adenovirus Ad-SIRT6,after 24 h transfected adenovirus Ad-IL-32,after 24 h treated with 50μg/ml ox-LDL for 24 h).Lipid content in macrophages of each group was detected by oil red O staining.Results HE staining showed that the atherosclerotic plaque area of the control group was 0;the atherosclerotic plaque area of mice in atherosclerosis group was smaller than that in atherosclerosis+SIRT6^(-/-)group(P<0.05).The expression levels of SIRT6 in aorta tissue of mice in atherosclerosis group and atherosclerosis+SIRT6^(-/-)group were lower than those in control group,while the expression levels of IL-32 and ICAM-1 in aorta tissue of mice were higher than those in control group(P<0.05).The expression levels of SIRT6 in aorta tissue of mice in atherosclerosis+SIRT6^(-/-)group were lower than those in atherosclerosis group,while the expression levels of IL-32 and ICAM-1 in aorta tissue of mice were higher than those in atherosclerosis group(P<0.05).Immunofluorescence staining showed that the intima of blood vessels in the control group was smooth and complete without thickening;atherosclerotic plaque was formed and the intima surface was not smooth and incomplete in the atherosclerotic group;compared with the atherosclerosis group,obvious lipid deposition was observed under the intima of the blood vessels in the atherosclerosis+SIRT6^(-/-)group,and the intima surface was less smooth and incomplete.Oil red O staining showed that no lipid accumulation was found in macrophages of the control group;the lipid content of macrophages in the atherosclerosis group was significantly increased compared with that in the control group;the lipid content in macrophages of atherosclerosis+AdSIRT6 group was significantly reduced compared with that of atherosclerosis group;the lipid content in macrophages of atherosclerosis+Ad-SIRT6+Ad-IL-32 group was significantly increased compared with that of atherosclerosis+Ad-SIRT6 group.Conclusion SIRT6 can inhibit the inflammatory response by down-regulating the expression of IL-32,thereby improving the function of endothelial cells,reducing lipid deposition in macrophages,and thus reducing the formation of foam cells,thus inhibiting the formation of atherosclerotic plaques,and ultimately delaying the progress of atherosclerosis.
作者 王婷婷 程锦 任何 李文杰 赵晓洁 薛玉刚 WANG Tingting;CHENG Jin;REN He;LI Wenjie;ZHAO Xiaojie;XUE Yugang(Department of Cardiology,Tangdu Hospital,Air Force Medical University,Xi'an 710032,China)
出处 《实用心脑肺血管病杂志》 2023年第4期83-88,共6页 Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
基金 国家自然科学基金青年科学基金项目(82200404)。
关键词 动脉粥样硬化 SIRT6 C57BL小鼠 巨噬细胞 Atherosclerosis SIRT6 C57BL mouse Macrophages
  • 相关文献

参考文献2

二级参考文献24

  • 1程光辉,谢芳,黄尾平,张劲林,韩宏伟.强化辛伐他汀对急性冠脉综合征合并慢性肾功能不全患者肾功能的影响[J].内科急危重症杂志,2020,0(1):25-28. 被引量:10
  • 2Salvayre R, Auge N, Benoist H, et al. Oxidized low-density lip- oprotein-induced apoptosis [ J]. Biochim Biophys Acta, 2002, 1585(2) : 213 -221.
  • 3Berliner JA, Heinecke JW. The role of oxidized lipoproteins in athero- genesis[J]. Free Radic Biol Med,1996,20(5) :707 -727.
  • 4Stewart BW, Nagarajan S. Recombinant CD36 inhibits ox-LDL- induced ICAM-1 -dependent monocyte adhesion [ J ]. Mol Immu- nol,2006,43 ( 3 ) :255 - 267.
  • 5Yasunobu Y, Hayashi K, Shingu T, et al. Coronary atheroscle- rosis and oxidative stress as reflected by autoantibodies against ox- idized low-density lipoprotein and oxysterols[ J]. Atherosclerosis, 2001, 155(2) : 445 -453.
  • 6De Lemos JA, Morrow DA. Brain Natriuretic Peptide Measurement in Acute Coronary Syndromes Ready for Clinical Application[ J] .9 Circulation, 2002, 106(23) : 2868 -2870.
  • 7Sabatine MS, Morrow DA, de Lemos JA, et al. Multimarker ap- proach to risk stratification in non-ST elevation acute coronary syndromes simultaneous assessment of troponin I, C-reactive pro- tein, and B-type natriuretic peptide[ J]. Circulation, 2002, 105 (15) : 1760 -1763.
  • 8De Lemos JA, Morrow DA, Bentley JH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes[ J]. N Engl JMed, 2001, 345(14) : 1014 - 1021.
  • 9Packard CJ. Triacylglycerol-rich lipoproteins and the generation of small, dense low-density lipoprotein[ J]. Biochem Soc Trans, 2003, 31(5) : 1066 -1069.
  • 10黄敏,周洪莲,杨菲,庄世虹,聂斌.血清氧化低密度脂蛋白抗体水平与动脉粥样硬化危险性的关系[J].临床内科杂志,2008,25(9):636-638. 被引量:7

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部